MiMedx Group, Inc. (MDXG) stock
MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 12/3034% below fair value
$3.18+0.00 (0.00%)
Close on Nov 18, 2026Market cap $464.04MP/E –Yield –
MiMedx operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
MiMedx's operating income for the twelve months ending Sep 30, 2026 was -$25.14M, down 146.7% year over year. For fiscal 2025 it was $63.89M, up 8.5% from the year before. Over ten years it grew 10.1% a year on average. The highest annual figure on record is $63.89M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $63.89M | +8.5% |
| FY2024 | Dec 31, 2024 | $58.87M | +58.6% |
| FY2023 | Dec 31, 2023 | $37.12M | – |
| FY2022 | Dec 31, 2022 | -$14.73M | – |
| FY2021 | Dec 31, 2021 | -$7.05M | – |
| FY2020 | Dec 31, 2020 | -$45.40M | – |
| FY2019 | Dec 31, 2019 | -$21.16M | – |
| FY2018 | Dec 31, 2018 | -$3.92M | -108.5% |
| FY2017 | Dec 31, 2017 | $46.22M | +5128.8% |
| FY2016 | Dec 31, 2016 | $884.00K | -96.4% |
| FY2015 | Dec 31, 2015 | $24.36M | +243.2% |
| FY2014 | Dec 31, 2014 | $7.10M | – |
| FY2013 | Dec 31, 2013 | -$2.64M | – |
| FY2012 | Dec 31, 2012 | -$5.36M | – |
| FY2011 | Dec 31, 2011 | -$9.76M | – |
| FY2010 | Dec 31, 2010 | -$10.53M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$11.70M | -152.7% |
| Q2 FY2026 | Jun 30, 2026 | -$18.47M | -249.3% |
| Q1 FY2026 | Mar 31, 2026 | -$16.05M | -294.5% |
| Q4 FY2025 | Dec 31, 2025 | $21.08M | +90.7% |
| Q3 FY2025 | Sep 30, 2025 | $22.19M | +98.8% |
| Q2 FY2025 | Jun 30, 2025 | $12.37M | -47.2% |
| Q1 FY2025 | Mar 31, 2025 | $8.25M | -37.5% |
| Q4 FY2024 | Dec 31, 2024 | $11.05M | -28.6% |
| Q3 FY2024 | Sep 30, 2024 | $11.16M | +0.3% |
| Q2 FY2024 | Jun 30, 2024 | $23.45M | +116.3% |
| Q1 FY2024 | Mar 31, 2024 | $13.20M | – |
| Q4 FY2023 | Dec 31, 2023 | $15.49M | +36.9% |
| Q3 FY2023 | Sep 30, 2023 | $11.12M | – |
| Q2 FY2023 | Jun 30, 2023 | $10.84M | – |
| Q1 FY2023 | Mar 31, 2023 | -$340.00K | – |
| Q4 FY2022 | Dec 31, 2022 | $11.31M | +780.2% |
| Q3 FY2022 | Sep 30, 2022 | -$7.10M | – |
| Q2 FY2022 | Jun 30, 2022 | -$9.64M | – |
| Q1 FY2022 | Mar 31, 2022 | -$9.30M | – |
| Q4 FY2021 | Dec 31, 2021 | $1.29M | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.08M | – |
| Q2 FY2021 | Jun 30, 2021 | -$410.00K | – |
| Q1 FY2021 | Mar 31, 2021 | -$6.85M | – |
| Q4 FY2020 | Dec 31, 2020 | -$16.09M | – |
| Q3 FY2020 | Sep 30, 2020 | -$9.71M | -168.4% |
| Q2 FY2020 | Jun 30, 2020 | -$5.86M | – |
| Q1 FY2020 | Mar 31, 2020 | -$13.74M | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.87M | – |
| Q3 FY2019 | Sep 30, 2019 | $14.20M | +3706.4% |
| Q2 FY2019 | Jun 30, 2019 | -$17.07M | -1119.3% |
| Q1 FY2019 | Mar 31, 2019 | -$13.41M | -551.5% |
| Q4 FY2018 | Dec 31, 2018 | -$8.94M | -137.3% |
| Q3 FY2018 | Sep 30, 2018 | $373.00K | -95.8% |
| Q2 FY2018 | Jun 30, 2018 | $1.68M | -76.8% |
| Q1 FY2018 | Mar 31, 2018 | $2.97M | -52.0% |
| Q4 FY2017 | Dec 31, 2017 | $23.98M | – |
| Q3 FY2017 | Sep 30, 2017 | $8.84M | – |
| Q2 FY2017 | Jun 30, 2017 | $7.21M | – |
| Q1 FY2017 | Mar 31, 2017 | $6.19M | – |
| Q4 FY2016 | Dec 31, 2016 | -$8.85M | – |
See a number that looks wrong?